المؤلفون: Puente J; Medical Oncology, Hospital Clínico San Carlos. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, C/Profesor Martín Lagos, s/n 28040, Madrid, Spain. javierpuente.hcsc@gmail.com., González-Del-Alba A; Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., Sala-Gonzalez N; Medical Oncology, ICO Girona, Hospital Josep Trueta, Girona, Spain., Méndez-Vidal MJ; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC). Reina Sofía Hospital. University of Córdoba, Cordoba, Spain., Pinto A; Medical Oncology, University Hospital La Paz - IdiPAZ, Madrid, Spain., Rodríguez Á; Medical Oncology, Hospital Universitario de León, León, Spain., Cuevas Sanz JM; Medical Oncology, Hospital Universitario de la Ribera, Alcira, Spain., Muñoz Del Toro JR; Medical Department, Janssen-Cilag S.A., Madrid, Spain., Useros Rodríguez E; Medical Department, Janssen-Cilag S.A., Madrid, Spain., García García-Porrero Á; Medical Department, Janssen-Cilag S.A., Madrid, Spain., Vázquez S; Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain.

المصدر: BMC cancer [BMC Cancer] 2019 Aug 05; Vol. 19 (1), pp. 766. Date of Electronic Publication: 2019 Aug 05.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Abiraterone Acetate/*therapeutic use , Adenocarcinoma/*drug therapy , Antineoplastic Agents, Hormonal/*therapeutic use , Docetaxel/*therapeutic use , Prednisone/*therapeutic use , Prostatic Neoplasms, Castration-Resistant/*drug therapy , Taxoids/*therapeutic use, Abiraterone Acetate/adverse effects ; Age Factors ; Aged ; Aged, 80 and over ; Anemia/etiology ; Antineoplastic Agents, Hormonal/adverse effects ; Antineoplastic Combined Chemotherapy Protocols ; Asthenia/etiology ; Humans ; Kaplan-Meier Estimate ; L-Lactate Dehydrogenase/analysis ; Male ; Middle Aged ; Multivariate Analysis ; Pain/etiology ; Prednisone/adverse effects ; Progression-Free Survival ; Proportional Hazards Models ; Prospective Studies ; Spain ; Taxoids/adverse effects ; Treatment Outcome

المؤلفون: Lainez N; Department of oncology, Complejo Hospitalario de Navarra, Servicio Oncología Médica. Pabellón B 2ª planta. Hospital de día, C/ Irunlarrea, 3, 31008, Pamplona, Navarra, Spain. nuria.lainez.milagro@cfnavarra.es., García-Donas J; Department of oncology, Hospital Sanchinarro, C/ Oña, 10, 28050, Madrid, Spain. jgarciadonas@gmail.com., Esteban E; Department of oncology, Hospital Universitario Central de Asturias, Julián Clavería s/n, 33006, Oviedo, Spain. eestebang@seom.org., Puente J; Department of oncology, Hospital Clínico de Madrid, C/ Doctor Martín Lagos s/n, 28040, Madrid, Spain. jpuente.hcsc@salud.madrid.org., Sáez MI; Department of oncology, Hospital Universitario Clínico Virgen de la Victoria, Campus Universitario de Teatinos, s/n, 29010, Málaga, Spain. msaez.med@gmail.com., Gallardo E; Department of oncology, Parc Taulí Sabadell Hospital Universitari, Parc Taulí 1, 08208, Sabadell, Spain. egallardo@tauli.cat., Pinto-Marín Á; Department of oncology, Hospital Universitario La Paz, P de la Castellana 261, 28046, Madrid, Spain. alvaropintomarin@gmail.com., Vázquez-Estévez S; Department of oncology, Hospital Universitario Lucus Augusti, Lugar San Cibrao, S/N, 27003, Lugo, Spain. Sergio.Vazquez.Estevez@sergas.es., León L; Department of oncology, Hospital Santiago de Compostela, Travesía da Choupana, s/n, 15706, Santiago de Compostela, Spain. Luis.Leon.Mateos@sergas.es., García-Carbonero I; Department of oncology, Hospital Virgen de la Salud, Adva. De Barber, 30, 45004, Toledo, Spain. igcarbonero@yahoo.es., Suárez-Rodríguez C; Department of oncology, Hospital Vall d'Hebron, Ps Vall d'Hebron, 119-129, 8035, Barcelona, Spain. crisuarez08@gmail.com., Molins C; Department of oncology, Hospital Universitario Dr. Peset, Avda. Gaspar Aguilar 90, 46017, Valencia, Spain. molins_car@gva.es., Climent-Duran MA; Department of oncology, Instituto Valenciano de Oncología, Gregorio Gea, 31-1° Planta, 46009, Valencia, Spain. macliment@fivo.org., Lázaro-Quintela M; Department of oncology, Complexo Hospitalario Universitario de Vigo, Pizarro 22, 36204, Vigo, Spain. martin.lazaro.quintela@sergas.es., González Del Alba A; Department of oncology, Hospital Universitario Son Espases, Ctra Valldemossa, 79, 07010, Palma de Mallorca, Spain. aranzazu.gonzalezdelalba@ssib.es., Méndez-Vidal MJ; Department of oncology, Hospital Universitario Reina Sofía, Avda. Menéndez Pidal, s/n, 14004, Córdoba, Spain. mjosemv@yahoo.es., Chirivella I; Department of oncology, Hospital Clínico de Valencia, Avda Blasco Ibáñez, 17, 46010, Valencia, Spain. chirivella_isa@gva.es., Afonso FJ; Department of oncology, Complejo Hospitalario Arquitecto Marcide, Rúa da residencia s/n. San pedro de Leixa, 15405, Ferrol, Spain. Francisco.Javier.Afonso.Afonso@sergas.es., López-Brea M; Department of oncology, Hospital Marqués de Valdecilla, Avda. Valdecila s/n, 39008, Santander, Spain. marta.lopezbrea@gmail.com., Sala-González N; Department of oncology, ICO de Girona, Francia s/n, 17007, Gerona, Spain. nsgonzalez@iconcologia.net., Domenech M; Department of oncology, Hospital de Althaia Xarxa Asistencial Manresa, Dr. Joan Soler, 1-3, 08243, Barcelona, Spain. mdomenech@althaia.cat., Basterretxea L; Department of oncology, Hospital de Donostia, P° Dr. Beguiristain 109, 20014, San Sebastian, Spain. laura.basterrechea@osakidetza.net., Santander-Lobera C; Department of oncology, Hospital Miguel Servet, Avda Gómez Laguna 25, 50009, Zaragoza, Spain. csantlob@yahoo.es., Gil-Arnáiz I; Department of oncology, Hospital Reina Sofía, Carretera Tarazona, KM 3, 31500, Tudela, Spain. irenega6@hotmail.com., Fernández O; Department of oncology, Complejo Hospitalario Ourense. Hospital Santa María Nai, Ramón Puga, 52-54, 32005, Orense, Spain. ovidiofernandezcalvo@yahoo.es., Caballero-Díaz C; Department of oncology, Hospital General Universitario de Valencia, Avda Tres Cruces, s/n, 46014, Valencia, Spain. caballero_cri@gva.es., Mellado B; Department of oncology, IDIBAPS, Hospital Clinic i Provincial de Barcelona, Villarroel, 170, 08036, Barcelona, Spain. BMELLADO@clinic.ub.es., Marrupe D; Department of oncology, Hospital Universitario de Móstoles, Río Júcar s/n, 28935, Móstoles, Madrid, Spain. david.marrupe@gmail.com., García-Sánchez J; Department of oncology, Hospital Arnau de Vilanova, C/ San Clemente n 12, 46015, Valencia, Spain. joseche812@hotmail.com., Sánchez-Escribano R; Department of oncology, Hospital Universitario de Burgos, Avenida Cid Campeador, 96, 09005, Burgos, Spain. rsescribano@seom.org., Fernández Parra E; Department of oncology, H.U. Hospital de Valme, Ctra. de Cádiz Km. 548.9, 41014, Sevilla, Spain. evamfparra@yahoo.es., Villa Guzmán JC; Department of oncology, Hospital de Ciudad Real, Obispo Rafael Torija, 13005, Ciudad Real, Spain. jvillaguzman1@yahoo.es., Martínez-Ortega E; Department of oncology, Hospital Ciudad de Jaén, Avenida Ejercito Español 10, 23007, Jaén, Spain. esthermartinezz@yahoo.es., Belén González M; Department of oncology, Hospital Son Llatzer, Ctra. Manacor, km.4, Sont Frriol, 07198, Palma de Mallorca, Spain. mbgonzal@hsll.es., Morán M; Pfizer Madrid, Avda. de Europa, 20B, 28108, Alcobendas, Madrid, Spain. marina.moran@pfizer.com., Suarez-Paniagua B; Trial Form Support, Avda. de Europa, 20B, 28108, Alcobendas, Madrid, Spain. Beatriz.suarez@tfscro.com., Lecumberri MJ; Department of oncology, Complejo Hospitalario de Navarra, Servicio Oncología Médica. Pabellón B 2ª planta. Hospital de día, C/ Irunlarrea, 3, 31008, Pamplona, Navarra, Spain. mj.lecumberri.biurrun@navarra.es., Castellano D; Department of oncology, Hospital 12 de Octubre, Av. de Córdoba s/n, 28041, Madrid, Spain. cdanicas@hotmail.com.

المصدر: BMC cancer [BMC Cancer] 2016 Feb 22; Vol. 16, pp. 135. Date of Electronic Publication: 2016 Feb 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Carcinoma, Renal Cell/*drug therapy , Kidney Neoplasms/*drug therapy, Aged ; Antineoplastic Agents/therapeutic use ; Female ; Guideline Adherence/statistics & numerical data ; Humans ; Male ; Middle Aged ; Molecular Targeted Therapy/adverse effects ; Neoplasm Metastasis ; Practice Guidelines as Topic ; Spain